Browsing: NVONYSE
Carolina RudahA new peer-reviewed study based on data from nearly 2M individuals highlights a wide range of clinical benefits and…
wingedwolf The Centers for Medicare and Medicaid Services (CMS) on Friday announced 15 additional Medicare Part D drugs selected for…
Terminator3D/iStock via Getty ImagesBlockbuster weight loss medications from Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) lead Evaluate Pharma’s list of…
hapabapa/iStock Editorial via Getty ImagesNovo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as…
CRNovo Nordisk (NVO) and Eli Lilly (LLY), the undisputed leaders in the global obesity drug market, saw their stocks heading…
hapabapa/iStock Editorial via Getty ImagesNovo Nordisk’s (NVO) next-gen weight loss therapy, CagriSema, caused up to ~23% of weight loss compared…